N-(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-1-phenylcyclopentane-1-carboxamide

Catalog No. :
ACURYZ511
CAS No. :
663929-25-7
Molecular Formula :
C23H25N3O2
Molecular Weight :
375.47

IUPAC Name:N-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-1-phenylcyclopentane-1-carboxamide

N-(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-1-phenylcyclopentane-1-carboxamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-1-phenylcyclopentane-1-carboxamide
IUPAC NameN-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-1-phenylcyclopentane-1-carboxamide
Molecular FormulaC23H25N3O2
Molecular Weight375.47
SMILESO=C(C1(C2=CC=CC=C2)CCCC1)NC3=C(C)N(C)N(C4=CC=CC=C4)C3=O
InChI KeyDSZRDJQTEGAYAV-UHFFFAOYSA-N
SynonymN-(2,3-DIMETHYL-5-OXO-1-PHENYL(3-PYRAZOLIN-4-YL))(PHENYLCYCLOPENTYL)FORMAMIDE;N-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-1-phenylcyclopentane-1-carboxamide;Cyclopentanecarboxamide, N-(2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol-4-yl)-1-phenyl-
CAS No.663929-25-7

Synthetic Route by SureRoute

1. ACURYZ511 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACGDOE069 route compound structure diagram
    ACGDOE06922198-72-7 In Stock
  2. Plus
  3. ACSELK752 route compound structure diagram
    ACSELK75277-55-4 In Stock
  4. Then
  5. ACURYZ511 route product structure diagram
    ACURYZ511663929-25-7
Inquiry

2. ACURYZ511 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACGDOE069 route compound structure diagram
    ACGDOE06922198-72-7 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACURYZ511 route product structure diagram
    ACURYZ511663929-25-7
Inquiry

Comments (0)